Trial
NCT04840589
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Metastatic Malignant Solid Neoplasm
Intervention
BET Bromodomain Inhibitor ZEN-3694
Why stopped
Other - Pending amendment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-13